Educating for personalized medicine: A perspective from oncology

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 1, 2009, Pages 23-25

  Parkinson, D R ^a   Ziegler, J ^a  

^a Nodality Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CLINICAL EDUCATION; CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEDICARE; NOTE; PATIENT ADVOCACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

HUMANS; MEDICAL ONCOLOGY; PATIENT EDUCATION AS TOPIC; PERSONAL HEALTH SERVICES;

EID: 67650617779     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.76     Document Type: Note

References (5)

1. Parkinson, D.R. & Cesano, A. Patient-specific classification of malignant disease. Curr. Opin. Mol. Ther. (in press).
2. Hudson, T.J. Personalized medicine: a transformative approach is needed. Can. Med. Assoc. J. 180, 911-913 (2009).
3. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genet. Med. 11, 66-73 (2009).
4. Roden, D.M. et al. Pharmacogenomics: challenges and opportunities. Ann. Intern. Med. 145, 749-757 (2006).
5. Ramsey S.D. et al. Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests. Am. J. Manag. Care 2, 197-202 (2006).